3,308.7 2,338.8 (969.9) (29.3%) 4,433.9 5,535.2 1,101.3 24.8% Normalized Net Profit/3 903.1 523.8 (379.3) (42.0%) 815.9 1,128.2 312.4 38.3% /1 Including other income and share of profit from investments in
share at 66.3% contracting 1.7% QoQ and 13.7% YoY to THB 17,359mn, followed by Traditional media (Newspaper, Magazines and Radio) which has 13.1% market share or THB 3,418mn, declined by 4.8% QoQ and 25.5
28.3% compared to 31.6% which has an earnings per share of Bt1.52. However, excluding the special items for 2016, net profit attributable to equity holders of the Company will decrease by Bt 65.4 million
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
subsidiary therefore recorded loss on impairment of assets of Baht 41 million. Finance cost The financial cost for the third quarter of 2018 amounted to Baht 31 million and the financial cost to revenue from
consolidated financial statements has recorded loss from impairment of Baht 456 million consisting of impairment trademark. The consolidated loss of the year end 2019 is Baht 591 million, increasing by 115% from
by SREIT, the Company’s wholly owned subsidiary and REIT manager of SPRIME. Net proceed was recorded as unearned revenue in the Company’s consolidated financial statement and would be recognized as
, primarily due to gain from fair value adjustment of investment property at THB 794m realized in 2Q18. The Company made the first dividend payment which was made from 2018 Net profit at THB 0.04 per share on
2017. The consolidated SG&A expenses in 2018 were 8.24% of total sales, slightly increased from 7.78% in 2017. Share of Profit from Associated Company The consolidated share of profit from associated